Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Genta clarifies Genasense agreement terms

Jan. 29, 2004

SuperGen completes rolling NDA for Orathecin

Jan. 29, 2004

First European named patient sales of Voraxaze

Jan. 29, 2004

ARC-111, a novel topoisomerase I antitumor candidate

Jan. 29, 2004

Atiprimod granted orphan drug status for multiple myeloma

Jan. 28, 2004

Zentaris and Solvay to advance LHRH antagonists through collaboration

Jan. 28, 2004

German approval for three-month Eligard

Jan. 28, 2004

Epigallocatechin-3 gallate inhibits VEGF-induced angiogenesis in vitro

Jan. 28, 2004

Inex and Enzon partner to develop Onco TCS

Jan. 27, 2004

Velcade recommended for approval in Europe

Jan. 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...